9 research outputs found
Midwall Fibrosis: Cardiac Magnetic Resonance Imaging in Risk Stratifying Cardiomyopathies
No full textThe United Kingdom’s National Institute for Health and Care Excellence guidance on implantable cardiac defibrillator (ICD) therapy recommend ICD in those with left ventricular dysfunction and a high risk of sudden cardiac death (SCD). SCD accounts for 30% deaths in non-ischaemic dilated cardiomyopathy (DCM), however risk stratifying and predicting SCD in DCM is a major management challenge. We present two cases demonstrating the potential role of cardiac magnetic resonance imaging in risk stratifying DCM
Contrast-Enhanced Cardiac Magnetic Resonance Imaging Accurately Differentiates Ischemic from Non-Ischemic Etiologies in Newly Diagnosed Cardiomyopathy
No full textThe prevalence and prognostic significance of right ventricular systolic dysfunction in nonischemic dilated cardiomyopathy
No full text10.1161/CIRCULATIONAHA.113.002518Circulation128151623-1633CIRC
Clinical utility and prognostic value of left atrial volume assessment by cardiovascular magnetic resonance in non-ischaemic dilated cardiomyopathy
No full text10.1093/eurjhf/hft019European Journal of Heart Failure156660-67
Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy
No full text10.1001/jama.2013.1363JAMA - Journal of the American Medical Association3099896-90
